Terms: = Brain cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
28 results:
1. GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma.
Qiao X; Chen Y; Wang Z; Peng N; Niu W; Hou S; Wu J; Ji Y; Niu C; Cheng C
Cancer Gene Ther; 2023 Dec; 30(12):1702-1714. PubMed ID: 37845349
[TBL] [Abstract] [Full Text] [Related]
2. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
McKnight D; Morales A; Hatchell KE; Bristow SL; Bonkowsky JL; Perry MS; Berg AT; Borlot F; Esplin ED; Moretz C; Angione K; Ríos-Pohl L; Nussbaum RL; Aradhya S; ; Haldeman-Englert CR; Levy RJ; Parachuri VG; Lay-Son G; de Montellano DJD; Ramirez-Garcia MA; Benítez Alonso EO; Ziobro J; Chirita-Emandi A; Felix TM; Kulasa-Luke D; Megarbane A; Karkare S; Chagnon SL; Humberson JB; Assaf MJ; Silva S; Zarroli K; Boyarchuk O; Nelson GR; Palmquist R; Hammond KC; Hwang ST; Boutlier SB; Nolan M; Batley KY; Chavda D; Reyes-Silva CA; Miroshnikov O; Zuccarelli B; Amlie-Wolf L; Wheless JW; Seinfeld S; Kanhangad M; Freeman JL; Monroy-Santoyo S; Rodriguez-Vazquez N; Ryan MM; Machie M; Guerra P; Hassan MJ; Candee MS; Bupp CP; Park KL; Muller E; Lupo P; Pedersen RC; Arain AM; Murphy A; Schatz K; Mu W; Kalika PM; Plaza L; Kellogg MA; Lora EG; Carson RP; Svystilnyk V; Venegas V; Luke RR; Jiang H; Stetsenko T; Dueñas-Roque MM; Trasmonte J; Burke RJ; Hurst ACE; Smith DM; Massingham LJ; Pisani L; Costin CE; Ostrander B; Filloux FM; Ananth AL; Mohamed IS; Nechai A; Dao JM; Fahey MC; Aliu E; Falchek S; Press CA; Treat L; Eschbach K; Starks A; Kammeyer R; Bear JJ; Jacobson M; Chernuha V; Meibos B; Wong K; Sweney MT; Espinoza AC; Van Orman CB; Weinstock A; Kumar A; Soler-Alfonso C; Nolan DA; Raza M; Rojas Carrion MD; Chari G; Marsh ED; Shiloh-Malawsky Y; Parikh S; Gonzalez-Giraldo E; Fulton S; Sogawa Y; Burns K; Malets M; Montiel Blanco JD; Habela CW; Wilson CA; Guzmán GG; Pavliuk M
JAMA Neurol; 2022 Dec; 79(12):1267-1276. PubMed ID: 36315135
[TBL] [Abstract] [Full Text] [Related]
4. Socioeconomic Disparities in brain Metastasis Survival and Treatment: A Population-Based Study.
Rodrigues A; Li G; Bhambhvani H; Hayden-Gephart M
World Neurosurg; 2022 Feb; 158():e636-e644. PubMed ID: 34785360
[TBL] [Abstract] [Full Text] [Related]
5. Decreased income, unemployment, and disability after craniotomy for brain tumor removal: a South Korean nationwide cohort study.
Oh TK; Song IA; Kwon JE; Lee S; Choi HR; Jeon YT
Support Care Cancer; 2022 Feb; 30(2):1663-1671. PubMed ID: 34554281
[TBL] [Abstract] [Full Text] [Related]
6. Combining MRI and Histologic Imaging Features for Predicting Overall Survival in Patients with Glioma.
Rathore S; Chaddad A; Iftikhar MA; Bilello M; Abdulkadir A
Radiol Imaging Cancer; 2021 Jul; 3(4):e200108. PubMed ID: 34296969
[TBL] [Abstract] [Full Text] [Related]
7. Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer.
Xu C; Liu W; Li L; Wang Y; Yuan Q
J Cell Mol Med; 2021 Aug; 25(15):7335-7341. PubMed ID: 34255923
[TBL] [Abstract] [Full Text] [Related]
8. Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review.
Wei LD; Li C; Li D; Liu XJ; Li RT; Li LW; Wang JM; Zhou DB
Pituitary; 2021 Oct; 24(5):754-767. PubMed ID: 33982223
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of the Oncomine Pan-cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies.
Shah M; Takayasu T; Zorofchian Moghadamtousi S; Arevalo O; Chen M; Lan C; Duose D; Hu P; Zhu JJ; Roy-Chowdhuri S; Riascos RF; Chen H; Luthra R; Esquenazi Y; Ballester LY
J Mol Diagn; 2021 Feb; 23(2):171-180. PubMed ID: 33531134
[TBL] [Abstract] [Full Text] [Related]
10. Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors.
Qi L; Kogiso M; Du Y; Zhang H; Braun FK; Huang Y; Teo WY; Lindsay H; Zhao S; Baxter P; Zhao X; Yu L; Liu Z; Zhang X; Su JM; Adesina A; Yang J; Chintagumpala M; Perlaky L; Tsz-Kwong Man C; Lau CC; Li XN
Cancer Lett; 2020 Nov; 493():197-206. PubMed ID: 32891713
[TBL] [Abstract] [Full Text] [Related]
11. GATAD1 gene amplification promotes glioma malignancy by directly regulating ccnd1 transcription.
Zhang S; Gao M; Yu L
Cancer Med; 2019 Sep; 8(11):5242-5253. PubMed ID: 31286678
[TBL] [Abstract] [Full Text] [Related]
12. Random Skin Biopsies Before brain Biopsy for Intravascular Large B-Cell Lymphoma.
Yamada E; Ishikawa E; Watanabe R; Matsumura H; Sakamoto N; Ishii A; Tamaoka A; Hattori K; Obara N; Chiba S; Nakamagoe K; Matsuda M; Tsurubuchi T; Tomidokoro Y; Akutsu H; Zaboronok A; Shibuya M; Takano S; Matsumura A
World Neurosurg; 2019 Jan; 121():e364-e369. PubMed ID: 30261371
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-490-5P Targets ccnd1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
[TBL] [Abstract] [Full Text] [Related]
14. Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes?
Soike MH; McTyre ER; Hughes RT; Farris M; Cramer CK; LeCompte MC; Lanier CM; Ruiz J; Su J; Watabe K; Bourland JD; Munley MT; O'Neill S; Laxton AW; Tatter SB; Chan MD
J Neurooncol; 2018 Sep; 139(2):461-467. PubMed ID: 29740743
[TBL] [Abstract] [Full Text] [Related]
15. Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer.
Samir N; Matboli M; El-Tayeb H; El-Tawdi A; Hassan MK; Waly A; El-Akkad HAE; Ramadan MG; Al-Belkini TN; El-Khamisy S; El-Asmar F
J Cell Biochem; 2018 Aug; 119(8):6869-6881. PubMed ID: 29737552
[TBL] [Abstract] [Full Text] [Related]
16. Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study.
Penn AM; Bibok MB; Saly VK; Coutts SB; Lesperance ML; Balshaw RF; Votova K; Croteau NS; Trivedi A; Jackson AM; Hegedus J; Klourfeld E; Yu AYX; Zerna C; Borchers CH;
Biomarkers; 2018; 23(4):392-405. PubMed ID: 29385837
[TBL] [Abstract] [Full Text] [Related]
17. SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis.
Li YX; Yu ZW; Jiang T; Shao LW; Liu Y; Li N; Wu YF; Zheng C; Wu XY; Zhang M; Zheng DF; Qi XL; Ding M; Zhang J; Chang Q
Cancer Sci; 2018 Apr; 109(4):1263-1275. PubMed ID: 29369502
[TBL] [Abstract] [Full Text] [Related]
18. Associations between the neuron-specific glucocorticoid receptor (NR3C1) Bcl-1 polymorphisms and suicide in cancer patients within the first year of diagnosis.
Park S; Hong JP; Lee JK; Park YM; Park Y; Jeon J; Ahn MH; Yoon SC
Behav Brain Funct; 2016 Jul; 12(1):22. PubMed ID: 27401254
[TBL] [Abstract] [Full Text] [Related]
19. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Wibom C; Späth F; Dahlin AM; Langseth H; Hovig E; Rajaraman P; Johannesen TB; Andersson U; Melin B
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
[TBL] [Abstract] [Full Text] [Related]
20. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
[TBL] [Abstract] [Full Text] [Related]
[Next]
